IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 196 filers reported holding IMPAX LABORATORIES INC in Q3 2015. The put-call ratio across all filers is 2.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $58,782,000 | -60.0% | 4,436,376 | -28.5% | 1.42% | -64.2% |
| Q3 2016 | $147,049,000 | -24.5% | 6,204,588 | -8.2% | 3.96% | -23.6% |
| Q2 2016 | $194,753,000 | -10.0% | 6,757,558 | 0.0% | 5.18% | -11.8% |
| Q1 2016 | $216,377,000 | -27.5% | 6,757,558 | -3.2% | 5.88% | -13.2% |
| Q4 2015 | $298,476,000 | +19.2% | 6,980,266 | -1.8% | 6.77% | +25.0% |
| Q3 2015 | $250,352,000 | -2.9% | 7,110,266 | +26.7% | 5.42% | -3.5% |
| Q2 2015 | $257,719,000 | +666.8% | 5,612,348 | +682.7% | 5.61% | +655.2% |
| Q1 2015 | $33,609,000 | – | 717,058 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |